A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany
Authors
Keywords
-
Journal
Therapeutic Advances in Neurological Disorders
Volume 9, Issue 2, Pages 95-104
Publisher
SAGE Publications
Online
2016-01-09
DOI
10.1177/1756285615622736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Sclerosis: Current Knowledge and Future Outlook
- (2014) Christian P. Kamm et al. EUROPEAN NEUROLOGY
- Patient centered decision making: Use of conjoint analysis to determine risk–benefit trade-offs for preference sensitive treatment choices
- (2014) Leslie Wilson et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
- (2014) Kathrin S. Utz et al. Therapeutic Advances in Neurological Disorders
- Teriflunomide for the treatment of multiple sclerosis
- (2013) Clemens Warnke et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
- (2013) F. Reed Johnson et al. VALUE IN HEALTH
- A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis
- (2013) S. L. Shingler et al. JOURNAL OF MEDICAL ECONOMICS
- New and emerging disease modifying therapies for multiple sclerosis
- (2012) Shiv Saidha et al. Annals of the New York Academy of Sciences
- Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
- (2012) Martin S. Weber et al. CURRENT PHARMACEUTICAL DESIGN
- Interferon Beta and Glatiramer Acetate Therapy
- (2012) Corey A. McGraw et al. Neurotherapeutics
- Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
- (2011) John F.P. Bridges et al. VALUE IN HEALTH
- Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis
- (2011) Rachel Halpern et al. Patient Preference and Adherence
- Health outcomes in economic evaluation: the QALY and utilities
- (2010) S. J. Whitehead et al. BRITISH MEDICAL BULLETIN
- Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis
- (2010) Stephanie C. Steinberg et al. CLINICAL DRUG INVESTIGATION
- The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
- (2010) V. Devonshire et al. EUROPEAN JOURNAL OF NEUROLOGY
- Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?
- (2009) Alessandra Lugaresi Expert Opinion on Drug Delivery
- Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy
- (2009) F. Reed Johnson et al. JOURNAL OF NEUROLOGY
- Factors that influence adherence with disease-modifying therapy in MS
- (2009) Katherine Treadaway et al. JOURNAL OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started